Mexityl 100 mg. 100 kapsuli.
Forma tad-dożaġġ
  • Kapsuli: 100 mg ta 'mexiletine kull wieħed.
  • Ippakkjar: 100 kapsula.
Jekk jogħġbok innota li d-dehra tal-ippakkjar tista 'tvarja skont il-manifattur u r-reġjun tal-bejgħ.
Ingredjent attiv

Mexiletine hija mediċina antiarritmika tal-klassi IB li tistabbilizza l-membrani tal-kardjomijoċiti u tnaqqas l-eċitabbiltà tagħhom.

Dożaġġ

Adulti:

  • Doża Inizjali: Normalment 200 mg (2 kapsuli ta’ 100 mg) kull 8 sigħat.
  • Doża ta’ Manteniment: Tista’ tiġi aġġustata skont ir-rispons kliniku u t-tolleranza, ġeneralment bejn 200 mg u 300 mg kull 8 sigħat.
  • Doża Massima Kuljum: M’għandhiex taqbeż 1200 mg.

Kif tuża:

  • Il-kapsuli għandhom jittieħdu oralment, billi tixrob biżżejjed ilma, irrispettivament mill-ikel.

Mexitil is the trade name for a medication containing mexiletine, a class IB antiarrhythmic agent. It is used for the treatment and prevention of various cardiac rhythm disorders.

Indications for Use:

  1. Ventricular Arrhythmias:
    • Treatment and prevention of symptomatic ventricular arrhythmias, including ventricular tachycardia.
  2. Supraventricular Arrhythmias:
    • For cases where other treatment options are ineffective or contraindicated.

Contraindications:

  • Known hypersensitivity to mexiletine or any components of the drug.
  • Cardiogenic Shock.
  • Sick Sinus Syndrome, unless a pacemaker is present.
  • Second- or Third-Degree Atrioventricular Block, unless the patient has a pacemaker.
  • Severe bradycardia.

Side Effects:

  1. Central Nervous System:
    • Dizziness, tremor, blurred vision, headache, nervousness, drowsiness.
  2. Gastrointestinal System:
    • Nausea, vomiting, heartburn, abdominal pain.
  3. Cardiovascular System:
    • Hypotension, worsening of arrhythmias, bradycardia.
  4. Allergic Reactions:
    • Skin rash, pruritus (itching).

Special Instructions:

  1. Therapy Monitoring:
    • Regular monitoring of ECG and plasma mexiletine levels is recommended to optimize dosage and minimize the risk of side effects.
  2. Hepatic and Renal Impairment:
    • In patients with liver or kidney dysfunction, dose adjustments and careful monitoring are necessary.
  3. Drug Interactions:
    • Mexiletine may interact with other antiarrhythmic agents, beta-blockers, and CYP2D6 inhibitors. Use caution when combining therapies.
  4. Pregnancy and Lactation:
    • Use is permitted only under strict medical indications and supervision.
  5. Consultation Recommended:
    • Before initiating treatment with Mexitil, consult a healthcare provider to evaluate the appropriateness of therapy and determine the optimal dosage. Self-medication is not advised and may result in adverse effects.
Mexityl 100 mg. 100 kapsuli.